Cognitive impairment is a common neurological comorbidity in renal disease patients and people with diabetes. The percentage of diabetic patients at risk of developing cognitive impairment is 5 times higher than non-diabetics. Similar, the percentage of comorbidity of cognitive decline in patients with chronic renal disease reaches almost 50%, while it increases further in older patients.
Cognitive decline in patients with renal disease and/or diabetes can go undiagnosed since it is not the focus of therapeutic interventions in these patients. The declined cognitive performance can have devastating outcomes at the quality of life of patients and their families.
In this Research Topic, Frontiers in Human Neuroscience is looking to address key aspects of the cognitive decline in renal disease and patients with diabetes to promote the discussion around this topic and to facilitate knowledge dissemination in the field.
We expect to attract significant contributions from diverse specialists in the field of neurological implications of renal disease and diabetes, to establish new trends for future studies.
We particularly welcome submission of Original Research, Review, Methods, and Perspective articles on the following sub-topics:
- New insights on the mechanisms renal disease and/or diabetes cause cognitive decline in patients
- Correlation of cognitive impairment severity and severity of renal disease and/or diabetes
- Brain network dynamics in patients with renal disease and/or diabetes
- EEG studies on brain activity alterations in these diseases
- Review and opinion articles on new perspectives in the study of cognitive decline in patients with renal disease and/or diabetes
- Novel methods for early identification of cognitive decline in patients
- Therapeutic interventions for the amelioration of the cognitive burden renal disease and diabetes inflicts on patients.
- Comorbidity of cognitive impairment and other neuropsychiatric diseases in patients with renal disease and/or diabetes
Cognitive impairment is a common neurological comorbidity in renal disease patients and people with diabetes. The percentage of diabetic patients at risk of developing cognitive impairment is 5 times higher than non-diabetics. Similar, the percentage of comorbidity of cognitive decline in patients with chronic renal disease reaches almost 50%, while it increases further in older patients.
Cognitive decline in patients with renal disease and/or diabetes can go undiagnosed since it is not the focus of therapeutic interventions in these patients. The declined cognitive performance can have devastating outcomes at the quality of life of patients and their families.
In this Research Topic, Frontiers in Human Neuroscience is looking to address key aspects of the cognitive decline in renal disease and patients with diabetes to promote the discussion around this topic and to facilitate knowledge dissemination in the field.
We expect to attract significant contributions from diverse specialists in the field of neurological implications of renal disease and diabetes, to establish new trends for future studies.
We particularly welcome submission of Original Research, Review, Methods, and Perspective articles on the following sub-topics:
- New insights on the mechanisms renal disease and/or diabetes cause cognitive decline in patients
- Correlation of cognitive impairment severity and severity of renal disease and/or diabetes
- Brain network dynamics in patients with renal disease and/or diabetes
- EEG studies on brain activity alterations in these diseases
- Review and opinion articles on new perspectives in the study of cognitive decline in patients with renal disease and/or diabetes
- Novel methods for early identification of cognitive decline in patients
- Therapeutic interventions for the amelioration of the cognitive burden renal disease and diabetes inflicts on patients.
- Comorbidity of cognitive impairment and other neuropsychiatric diseases in patients with renal disease and/or diabetes
